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Article
language impairment in Huntington’s disease
Alterações de linguagem na doença de Huntington
Mariana Jardim Azambuja1, Marcia Radanovic2, Mônica Santoro Haddad3, Carla Cristina Adda4, Egberto 
Reis Barbosa5, Letícia Lessa Mansur6
Huntington’s disease (HD) is an autosomal dominant 
degenerative disorder, determined by a mutation on the 
short arm of the fourth chromosome (4p16.3), leading to 
an unstable expanded CAG trinucleotide repeat in the 
huntingtin gene (between 39 and 86). The huntingtin gene 
encodes the huntingtin protein, a large protein thought to 
be important for gene transcription, energy homeostasis 
and vesicle function. The larger the number of repetitions, 
the earlier and the faster is the progression of the disease. 
HD is characterized by progressive mental and motor 
alterations. The prevalence of HD is about 5-10/100,000 in 
populations of European origin, but somewhat less com-
mon in non-European populations. Chorea is the more 
prominent among the motor alterations, and may be pres-
ent in up to 90% of affected patients. Other frequent altera-
tions in HD are dysarthria, postural imbalance, ocular dys-
function, hypotonia and bradikinesia, associated or not to 
rigidity. Regarding mental alterations, dementia, personal-
ity changes, humor disturbances and, more rarely, psycho-
sis occur in these patients1,2. 
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AbstrAct
Language alterations in Huntington’s disease (HD) are reported, but their nature and correlation with other cognitive impairments are still 
under investigation. This study aimed to characterize the language disturbances in HD and to correlate them to motor and cognitive aspects 
of the disease. We studied 23 HD patients and 23 controls, matched for age and schooling, using the Boston Diagnostic Aphasia Examina-
tion, Boston Naming Test, the Token Test, Animal fluency, Action fluency, FAS-COWA, the Symbol Digit Modalities Test, the Stroop Test and the 
Hooper Visual Organization Test (HVOT). HD patients performed poorer in verbal fluency (p<0.0001), oral comprehension (p<0.0001), repeti-
tion (p<0.0001), oral agility (p<0.0001), reading comprehension (p=0.034) and narrative writing (p<0.0001). There was a moderate correlation 
between the Expressive Component and Language Competency Indexes and the HVOT (r=0.519, p=0.011 and r=0.450, p=0.031, respectively). 
Language alterations in HD seem to reflect a derangement in both frontostriatal and frontotemporal regions.
Key words: Huntington disease, language, movement disorders, frontal lobe, caudate nucleus.
resumo
Alterações de linguagem são descritas na doença de Huntington (DH), mas sua natureza exata e a correlação com outras funções cognitivas 
ainda estão em investigação. Os objetivos deste estudo foram caracterizar o prejuízo de linguagem na DH e correlacioná-lo aos aspectos motores 
e cognitivos da doença. Foram estudados 23 pacientes com DH e 23 controles, equiparados quanto à idade e escolaridade. Usamos os testes de 
Boston para Diagnóstico da Afasia, de Nomeação de Boston, Token, Modalidades de Símbolos e Dígitos, Stroop, Organização Visual de Hooper 
(TOVH), fluência de animais, fonêmica e verbos. Pacientes com DH apresentaram pior desempenho na fluência verbal (p<0,0001), compreensão 
oral (p<0,0001), repetição (p<0,0001), agilidade oral (p<0,0001), compreensão de leitura (p=0,034) e narrativa escrita (p<0,0001). Houve correlação 
moderada entre os índices Componente de Expressão e Competência de Linguagem e o TOVH (r=0,519, p=0,011 e r=0,450, p=0,031, respectiva-
mente). Alterações de linguagem na DH parecem refletir prejuízos nas regiões frontostriatais e frontotemporais.
Palavras-Chave: doença de Huntington, linguagem, transtornos motores, lobo frontal, núcleo caudado.
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Except for verbal fluency, which has been well stud-
ied3, there are few descriptions of other language altera-
tions in HD and there is no consensus about its determi-
nants. Impairment in motor speech production has been 
reported more frequently4, and the linguistic aspects are 
less well understood. This may be due, in part, to the fact 
that most patients have dysarthria and develop dementia 
or psychotic symptoms, thus hampering cognitive evalua-
tion. This may also be due to language alterations occur-
ring late in the course of the disease, when an appropriate 
evaluation is far more difficult because of the aforemen-
tioned reasons.  
To the best of our knowledge, there are no studies spe-
cifically addressing language disturbances in HD taking into 
account all concurrent motor, psychiatric and cognitive (ex-
tralinguistic) alterations. The aims of this study were: a) to 
characterize the language alterations in a sample of HD pa-
tients; b) to correlate such language alterations with cogni-
tive (extralinguistic), psychiatric and motor findings. 
metHoDs
We studied 23 HD patients diagnosed by a neurologist 
taking into consideration the clinical findings and a positive 
family history for HD, according to the criteria established 
by Folstein et al.5. In 15 cases the diagnosis was genetical-
ly confirmed. Patients who presented other neurological or 
psychiatric disorders, hearing deficiency or disturbances in 
the acquisition of language were not included in this study. 
To determine the duration of the disease, we considered the 
reports by patients and family members regarding the ear-
liest symptoms whether motor, cognitive or psychiatric. In 
one case, the clinical manifestations appeared prior to the 
age of 20 (juvenile HD).
At the time of evaluation, five patients (21.7%) were not 
on medication. Sixteen patients were taking antipsychotic 
drugs: 13 (56.5%) were taking haloperidol (doses ranging 
from 2 to 25 mg) and three (13%) were taking olanzapine 
(2.5 mg). Fifteen patients (62.5%) were taking SSRI antide-
pressants: 13 (56.5%) were taking sertraline (doses ranging 
from 50 to 200 mg) and one patient was taking fluoxetine 
(40 mg). One patient was taking a tryciclic anitdepressant 
(nortriptyline, 10 mg). Three patients were taking clonaze-
pam in doses ranging from 0.5 to 2 mg.
The control group was composed by 23 normal subjects 
matched for gender, age and schooling. The subjects en-
rolled as controls were required to achieve normal scores in 
the Mini Mental State Examination (MMSE)6 and fulfill the 
“Mayo Older American Normative Studies” (MOANS)7 cri-
teria, adapted for non-elderly adults. The control group was 
recruited from caregivers who were not genetically related 
to the patients and from the community. All subjects were 
Brazilian Portuguese native speakers; one patient and two 
controls were left-handed. 
The motor and cognitive evaluation was performed us-
ing the Brazilian version of the Unified Huntington’s Disease 
Rating Scale (UHDRS)8,9, which addresses four domains of 
clinical and functional performance: motor function, be-
havioral abnormalities, cognitive function and functional 
capacity. The cognitive evaluation included the MMSE, the 
FAS-COWA, the Digit Symbol Modalities Test (DSMT)10, 
the Stroop Test11 and the Hooper Visual Organization Test 
(HVOT)12. The HVOT was adapted so as to make it possible 
to differentiate between visual (discriminative) errors and 
naming errors. Thus, if the subject replied incorrectly in the 
visual organization task, the pictures were then organized 
and re-presented, only to be named. In this “visual confron-
tation naming task”, semantic cues and phonemic cues were 
also given. Depressive symptoms were assessed using the 
Montgomery-Asberg Depression Rating Scale (MADRS)13.
Language was examined addressing oral comprehen-
sion, oral production, written comprehension and writ-
ten production through the following batteries: the Token 
Test, Reduced Version14, the Boston Diagnostic Aphasia 
Examination (BDAE)15, Short Version, complemented by 
the subtests Word Discrimination, Following Commands, 
Complex Ideational Material, Naming of Special Categories, 
and Syntactic Processing from the Extended Version, the 
Boston Naming Test (BNT)16, Animal fluency, and Action flu-
ency. A qualitative analysis of naming errors was performed 
according to the criteria proposed by Hodges et al.17. The ex-
istence of dysarthria and its severity was evaluated following 
the criteria proposed by Yorkston18.
Three language indexes proposed by Goodglass et al.15 
were employed in order to perform the correlation between 
language performance and motor, cognitive and psychiatric 
symptoms, as well as with the duration of disease: Expression 
Component (mean scores on the BNT and Grammatical 
Form), Comprehension Component (mean scores on the 
subtests Word Discrimination, Following Commands 
and Complex Ideational Material), and the Language 
Competency Index (composed by the mean scores of the lan-
guage Expression and Comprehension indexes).
All evaluations were performed by the same investigator 
(MJA) in a silent room. Language tests were performed with-
out time restriction, in order to prevent that motor difficul-
ties or dysarthria could hamper the patients’ performance in 
those tasks when such abilities were not being specifically 
addressed. The UHDRS (motor and functional subscales) and 
the MADRS scales were administered by a neurologist, and a 
neuropsychologist was responsible for the cognitive (extra-
linguistic) evaluation. 
All subjects enrolled in this study signed a consent form, 
and the study was approved by the Ethics Committee in the 
hospital where it was conducted.
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statistical analysis
The two groups (controls and HD) were compared re-
garding demographical and clinical characteristics using 
Student’s t-test and the χ2 test, as appropriate. The per-
formance of both groups on neuropsychological and lan-
guage tests was compared by means of the Student’s t-test. 
Pearson correlations were used to analyze associations 
between the indexes of language performance and motor, 
functional, cognitive, and psychiatric alterations, as well as 
with the duration of the disease in HD patients. We used a 
significance level of 0.05 for all analyses. All analyses were 
performed using the software Statistical Package for Social 
Sciences (SPSS®) for Windows version 10.0.
results
Data regarding the demographical composition of the 
sample, cognitive (extralinguistic) and motor performance, 
and duration of the disease are displayed in Table 1. HD pa-
tients performed poorer than controls in all neuropsycho-
logical tests. 
Regarding oral language comprehension, HD patients 
had statistically significant poorer performance than con-
trols in the Word Discrimination, Following Commands, 
Complex Ideational Material and Syntactic Processing 
tasks. In the Token test, there were no differences in perfor-
mance in parts 1, 2 and 3, but HD patients performed poor-
er than controls in parts 4 (p=0.017), 5 (p=0.011), 6 (p=0.006) 
(raw data not shown) and in the total score. In oral language 
production, HD patients had statistically significant poorer 
performance than controls in Verbal Agility, Non Verbal 
Agility, Words Repetition, Sentence Repetition and Action 
Naming (Table 2). In the Animal fluency, Action fluency 
tasks and in the FAS-COWA, HD patients performed poorer 
than controls (Tables 1 and 2). 
In the BNT, there were not significant differences be-
tween the groups in the number of spontaneous correct re-
sponses. The qualitative analysis of types of errors revealed 
that HD patients differed from controls only in errors of the 
type “I don’t know” and “not related to the target” (Table 3). 
In written language comprehension, HD patients had 
lower scores than controls only in the Reading Paragraphs 
and Sentences task. In written language production, HD pa-
tients had lower scores in the Letter Form, Letter Choice, 
Motor Facility and Narrative Writing tasks. In the Narrative 
Writing (Cookie Theft Picture), HD patients performed 
poorer in Mechanics (p=0.002), Vocabulary (p<0.0001), 
Content (p<0.0001) (raw data not shown) and in the total 
score (Table 2).
HD patients also had lower scores than controls in the 
three indexes of global language performance, namely 
Comprehension Component, Expression Component and 
Language Competency Index (Table 2).
There were not any correlations between language per-
formance (as measured by its three indexes of global lan-
guage performance) and the UHDRS scores (motor and 
functional), MMSE, Stroop test, DSMT, MADRS and dura-
tion of the disease. There was a positive moderate significant 
correlation between the scores in the HVOT and both the 
Expression Component (r=0.519, p=0.011) and the Language 
Competency Index (r=0.450, p=0.031).
Variables
Controls (n=23) HD (n=23) HD (n=23) p-value  
(two-tailed)Mean (SD) Range Mean (SD) Range
Age (years) 47.3 (10.9) 21–63 46.9 (11.2) 19–65 0.905
Schooling (years) 9.6 (4.1) 4–20 9.6 (3.7) 4–16 0.970
Gender
M 8 (34.8%) 8 1.000
F 15 (65.2%) 15
Duration of disease (years) NA 6.8 (2.8) 3–12 –
UHDRS
Motor NA 46.2 (19.4) 12–86 –
Functional NA 6.61 (3.2) 1–12 –
MADRS NA 12.5 (6.8) 2–32 –
Dysarthria NA 8.3 (1.5) 5–10 –
MMSE 28.1 (1.4) 25–30 22.8 (3.2) 15–27 <0.0001
HVOT
Discriminative 20.5 (3.9) 11–27.5 11.3 (6.3) 2–24 <0.0001
Naming 28 (2) 23–30 24.5 (2.9) 19–30 <0.0001
DSMT 36.8 (14.4) 15–71 16 (8.9) 0–31 <0.0001
Stroop color/words
time (sec.) 29 (5.8) 19–41 72.6 (53) 5–261 0.001
errors 1.4 (1.6) 0–5 3.7 (3.6) 0–13 0.010
FAS-COWA 32.4 (8.5) 18–50 14.9 (8) 4–22 <0.0001
Table 1. General characteristics of the sample: demographic data, cognitive and motor performance, and duration of the disease.
SD: standard deviation; HD: Huntington’s disease; UHDRS: Unified Huntington’s Disease Rating Scale; MADRS: Montgomery-Asberg Depression Rating Scale; 
MMSE:  Mini Mental State Examination; HVOT: Hooper Visual Organization Test; DSMT:  Digit Symbol Modalities Test; NA: not applicable.
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Language tests
Controls (n=23) HD (n=23) p-value  
(two-tailed)Mean (SD) Range Mean (SD) Range
Token test 32.4 (2.2) 29–36 28.6 (5) 16–36 0.003
Action fluency 12.5 (5.3) 5–30 6.5 (4.3) 0–15 <0.0001
Animal fluency 16.5 (4.6) 10–25 9.1 (4) 3–17 <0.0001
BDAE
Word comprehension 15.3 (0.7) 14–16 14.4 (1.3) 12–16 0.004
Following commands 14.7 (0.5) 13–15 13.1 (1.8) 9–15 0.001
Complex ideational material 9.4 (2.2) 4–12 6.3 (2.8) 1–11 <0.0001
Syntactic processing 9.8 (2.4) 4–13 8.2 (2.8) 3–12 0.046
Non verbal agility 9.7 (1.7) 6–12 4.8 (2.1) 0–9 <0.0001
Verbal agility 12.8 (0.6) 14–14 10.1 (2.6) 3–13 <0.0001
Automatized sequences 3.9 (0.3) 3–4 3.9 (0.3) 3–4 1.000
Repetition of single words 14.2 (0.8) 14–15 14.6 (0.5) 13–15 0.050
Repetition of sentences 9 (0.9) 7–10 7.6 (1.5) 4–10 <0.0001
Responsive naming 19.8 (0.8) 18–22 19.6 (0.6) 18–20 0.414
Letters naming 4 (0) 4–4 4 (0) 4–4 1.000
Numbers naming 3.9 (0.2) 3–4 4 (0) 4–4 0.328
Colors naming 3.7 (0.4) 3–4 3.7 (0.5) 3–4 0.750
Action naming 9.3 (1.9) 6–12 7.9 (2.2) 3–11 0.028
Matching across cases and scripts 7.8 (0.5) 6–8 7.1 (1.6) 3–8 0.070
Number matching – fingers to Arabic numbers 2 (0) 2–2 2 (0) 2–2 1.000
Number matching – arabic numbers to dot patterns 2 (0) 2–2 1.7 (0.5) 1–2 0.005
Picture – word matching 3.6 (0.6) 2–4 3.3 (0.9) 1–4 0.351
Oral word reading 14.7 (1.2) 9–15 14.3 (2.5) 3–15 0.514
Oral sentences reading 8.6 (1.5) 6–10 7.7 (1.9) 3–10 0.079
Oral sentence comprehension 4.2 (1) 1–5 3.8 (1.3) 1–5 0.205
Reading comprehension – sentences and paragraphs 7.3 (1.5) 5–10 6.2 (1.9) 0–10 0.034
Letter form 13.5 (1.2) 9–14 10.3 (3.2) 2–14 <0.0001
Letter choice 20.6 (0.9) 17–21 18.3 (2.8) 8–21 0.001
Motor facility 13.9 (0.2) 13–14 8.8 (4.2) 0–14 <0.0001
Dictation – primer words 4 (0.5) 3–6 3.8 (0.8) 0–4 0.151
Dictation – regular phonics 2 (0.7) 1–5 1.8 (0.5) 0–2 0.233
Dictation – common irregular words 2.8 (0.7) 1–5 2.8 (0.6) 0–3 0.833
Written picture naming 2.6 (0.6) 1–4 2.6 (0.8) 0–4 0.840
Narrative writing 9.2 (1.6) 5–11 6.6 (2.2) 0–10 <0.0001
Language competency indexes
Comprehension component 79.9 (11) 60–100 51.7 (18.6) 26–90 <0.0001
Expression component 86.5 (8.4) 75–100 81.5 (7.8) 65–95 0.032
Language competency index 82.9 (8.5) 67.5–100 66.6 (12) 45.8–92.5 <0.0001
Table 2. Performance of Huntington’s disease and control groups in the Token Test, Animal fluency, Action fluency and BDAE.
BDAE: Boston Diagnostic Aphasia Examination. 
BNT: Boston Naming Test; SD: standard deviation.
Variable
Controls (n=23) HD (n=23) p-value  
(two-tailed)Mean (SD) Range Mean (SD) Range
Correct responses (spontaneous) 41.6 (7.4) 24–55 37.2 (8.7) 23–54 0.073
Semantic cues 1.35 (1) 0–3 2 (1.8) 0–6 0.146
Phonemic cues 6.22 (4.4) 1–22 9.35 (3.6) 2–15 0.012
Total 49.2 (6.2) 38–59 48.6 (5.6) 40–57 0.729
Error type
“I don’t know” 2.4 (2.5) 0–8 6.4 (7) 0–24 0.016
Visual 2.5 (1.9) 0–6 3.5 (2.6) 0–8 0.187
Visual and semantic 1.4 (1.4) 0–6 2 (1.6) 0–6 0.158
Same semantic category 0.5 (0.8) 0–2 0.4 (0.6) 0–2 0.688
Superordinate 1.5 (1.1) 0–4 1.1 (0.9) 0–3 0.256
Semantic association 4.7 (2.3) 1–10 4.5 (2.4) 1–9 0.754
Circumlocutions 2.3 (2.2) 0–10 2.7 (2.5) 0–9 0.580
Phonological 0.2 (0.5) 0–2 0.2 (0.5) 0–2 1.000
Perseveration 0.08 (0.3) 0–1 0.2 (0.5) 0–2 0.468
Not related to the target 0.8 (1) 0–3 2.5 (2.4) 0–8 0.005
Table 3. Performance of Huntington’s disease and control groups in the BNT.
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DiscussioN
Language alterations in HD are scarcely described and, 
according to Lepron et al.19, are primarily related to frontal 
functions, such as impairment in verbal fluency and syntac-
tic processing. Nadeau20 states that in HD the language disor-
ders can be pervasive, due to the neurodegeneration, which 
progresses far beyond the head of the caudate nucleus. Our 
discussion addresses the alterations found in different lin-
guistic aspects (phonetic, phonological, syntactic and se-
mantic), and proposes an interpretation that takes into ac-
count both linguistic and cognitive components of language.
Regarding the phonetic articulatory aspects, our findings 
were highly predictable, given that HD largely affects frontos-
triatal systems related to motor functions. Our patients were 
classified as having mild hyperkinetic dysarthria according 
to Yorkston18, which did not compromise speech intelligibil-
ity, and did not interfere with the patients’ scoring, except in 
tasks that demanded verbal agility.
HD patients did not present any difficulties in tasks re-
quiring preserved phonological loop, such as Repetition of 
Single Words and Dictation of Regular and Irregular Words. 
Integrity of the articulatory rehearsal processes, at least 
for short material, can thus be inferred. However, they did 
have impairment when repeating sentences. The Sentence 
Repetition task provides simple sentences in canonical order, 
being the number of syllables the only variable element.
Regarding the semantic aspects of language processing, we 
encountered deficits in the Word Comprehension, Following 
Commands and Complex Ideational Material tasks. The seman-
tic system contains trace representations in nets that merge 
the entire subject’s knowledge about a specific concept. The 
traces can be shared by several nets, thus making up catego-
ries. Traces can also be distinguishing features between related 
items, but these are assembled in a lesser number of nets. The 
Word Comprehension task of the BDAE demands the identifica-
tion of items within the same semantic category, thus relying on 
the ability to properly activate the distinguishing features.
Comprehension of Complex Ideational Material (orally pre-
sented) was impaired in HD patients, indicating an inability to 
retain and process lengthy and integrated information. Although 
it is reasonable to assume that working memory impairment 
may play a role in these findings, it is worth noting that similar 
difficulties were also found in the Reading Comprehension task, 
where information is printed and available to the subject while 
performing the task. Comprehension of complex material, pre-
sented either in oral or written form, depends on the interpreta-
tion of its semantic and syntactic components.
Semantic loss can also be inferred by the low performance 
of HD patients in verbal fluency tasks. Although action and 
letter fluency greatly rely on integrity of executive functions, 
animal fluency requires both executive functions and se-
mantic knowledge integrity. Low performance in letter and 
semantic fluency tasks in HD was reported by Henry et al.3 in 
a meta-analytic study, and a dissociation between semantic 
and letter fluency (with a poorer performance in letter fluen-
cy) has also been described21. Time restriction to perform the 
task may also be a factor that contributes to poor results22. 
Action fluency was worse in HD patients, a finding already 
reported by our group in a previous study23. Impaired verb 
generation in HD patients was described by Péran24, and such 
difficulties with action naming are hypothesized as being re-
lated to frontal dysfunction25.
Moreover, action naming was the naming task that best 
discriminated controls and HD patients; naming tasks are 
said to reflect an interface between language and motor ac-
tion26 and the interaction between semantic, executive and 
movement abnormalities, the latest two being linked to the 
derangement of frontostriatal circuits found in HD27.
The qualitative analysis of naming errors performed by 
HD patients do not allow any psycholinguistic interpretation, 
as the two types of errors in which HD differed from controls 
were “I don’t know” and “not related to the target”. HD pa-
tients did not take advantage from semantic cues in the BNT, 
thus suggesting that visuoperceptual impairment did not 
significantly compromise their naming performance, in spite 
of the evidence of visuospatial impairment in the HVOT. 
However, visuoperceptual difficulties are more evident in the 
written production tasks, such as Letter Choice. 
In summary, HD patients revealed deficits in situations 
requiring a more refined treatment of the material (e.g., vi-
sual-semantic differentiation), either when it was extensive 
or when its comprehension was somewhat complex, thus 
requiring integration of information and the realization of 
inferences. They also displayed impoverishment of content in 
the production of semi-spontaneous language as in the nar-
rative based on the Cookie Theft Picture. It is worthy to note 
that these deficits do not characterize aphasia, but difficul-
ties in high demanding tasks.
HD has been widely accepted as a disease of the basal gan-
glia, more specifically the head of caudate nucleus, and sever-
al studies have correlated the cognitive impairments found in 
HD to frontostriatal dysfunction occurring as a consequence of 
caudate atrophy, especially attentional deficits, working mem-
ory deficits and executive dysfunction19,20,27, which are already 
prominent in the early stages of the disease. Basal ganglia have 
been related to procedural learning and computational as-
pects of linguistic processes, as those necessary for syntactic 
processing28. There is also evidence of a role of the striatum in 
the retrieval of lexical information29. However, as the disease 
progresses, diffuse cortico-subcortical takes place, especially 
in frontal and temporal regions, and these findings correlate 
with increasing visuospatial, episodic memory and language 
disturbances20,30. Hence, it can be assumed that the deterio-
ration of the frontostriatal and, subsequently, the frontotem-
poral axis (including language areas) can explain the features 
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of semantic ad syntactic disturbances found in HD patients. 
These multiple deficits (in lexical access, comprehension, syn-
tax) quite certainly suffer the influence of working memory, 
executive functions and visuospatial abilities, which were all 
impaired in our patients, but also reflect the cortical diffuse 
derangement in HD18. The poor performance of HD patients 
in the HVOT and the moderate positive correlation between 
the Expression Component (which includes the scores in the 
BNT) and the Language Competency Indexes and the HVOT 
scores favor this interpretation. 
The complementary cognitive evaluation aimed to sup-
port some findings previously reported in HD patients, such 
as impaired verbal fluency, verbal comprehension, syntactic 
production and naming abilities. Such a comprehensive eval-
uation has helped us to better understand the nature of some 
phonological, syntactic and even semantic alterations in a 
broader context, for instance, that of executive dysfunction. 
Limitations of this study are the small sample of HD 
patients and the instrument used to assess language. The 
BDAE was designed for the diagnosis and classification of 
aphasia, and HD patients are not aphasics. Although the 
BDAE was well-suited for the purpose of screening the gen-
eral profile of language alterations in this sample of HD pa-
tients, further studies with more specific psycholinguistic 
instruments are warranted.
Finally, a question that cannot be overlooked: why pa-
tients suffering from HD (neither their relatives nor caregiv-
ers) do not complain of language difficulties? This may be 
due to the fact that once the disease is diagnosed, motor (in-
cluding dysarthria), psychiatric and global cognitive impair-
ment turn out to be so prominent as to surpass the linguistic 
disturbances, hence the importance of assessing and identi-
fying the linguistic deficits that might be overlooked in these 
patients, leading to additional impairment in quality of life.
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